This protocol applies to patients with Erysipeloid who cannot tolerate penicillin. Penicillin intolerance requires a defined alternative treatment strategy to ensure effective management of this bacterial skin infection.
For patients intolerant of penicillin, evidence supports the use of specific alternative antibiotic classes. The full protocol defines the applicable agents, selection criteria, and clinical context for each option.
Cephalosporins, clindamycin, or fluoroquinolones should be effective for those intolerant of penicillin.